Literature DB >> 3940648

Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3.

V G Johnson, J Schlom, A J Paterson, J Bennett, J L Magnani, D Colcher.   

Abstract

Monoclonal antibody B72.3 binds a high-molecular-weight tumor-associated glycoprotein identified as TAG-72. This study reports the partial purification and characterization of TAG-72 from a xenograft of a human carcinoma cell line, LS-174T, which expresses high levels of this antigen. The tumor homogenate was initially fractionated by Sepharose CL-4B chromatography. The high-molecular-weight TAG-72, found in the exclusion volume, was then subjected to two sequential passages through B72.3 antibody affinity columns. At each step of the procedure, TAG-72 content was quantitated using a competition radioimmunoassay, and the degree of purification was expressed as the ratio of antigen in units to total protein. The three-step procedure produced a purification of TAG-72 with minimal contamination by other proteins as shown by polyacrylamide gel electrophoresis, followed by staining with Coomassie Blue or periodic acid/Schiff reagent. The density of affinity-purified TAG-72, as determined by cesium chloride gradient ultracentrifugation, was found to be 1.45 g/ml. This density determination, together with the high molecular weight of TAG-72, its resistance to Chondroitinase digestion, the presence of blood group-related oligosaccharides, and sensitivity to shearing into lower-molecular-weight forms suggest that TAG-72 is a mucin-like molecule.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3940648

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  78 in total

1.  The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer.

Authors:  C X Zheng; W H Zhan; J Z Zhao; D Zheng; D P Wang; Y L He; Z Q Zheng
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  Monoclonal immunoscintigraphy for detection of metastasis and recurrence of colorectal cancer.

Authors:  Vera Artiko; Ana Koljevic Marković; Dragana Sobić-Šaranović; Milorad Petrović; Andrija Antić; Mirjana Stojković; Marinko Zuvela; Djordjije Saranović; Milica Stojković; Nebojša Radovanović; Danijel Galun; Aleksandar Milovanović; Jovica Milovanović; Anica Bobić-Radovanović; Zoran Krivokapic; Vladimir Obradović
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

3.  Overview of new treatments for breast cancer.

Authors:  G N Hortobagyi
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

4.  Differential mucin gene expression in human pancreatic and colon cancer cells.

Authors:  S Yonezawa; J C Byrd; R Dahiya; J J Ho; J R Gum; B Griffiths; D M Swallow; Y S Kim
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

Review 5.  Simple sugars to complex disease--mucin-type O-glycans in cancer.

Authors:  Matthew R Kudelka; Tongzhong Ju; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

6.  Evaluation of therapeutic response using iodine-131-B72.3 monoclonal antibody in patients with ovarian carcinoma.

Authors:  L Camera; S Del Vecchio; A Petrillo; G Esposito; G Frasci; R V Iaffaioli; A R Bianco; M Salvatore
Journal:  Eur J Nucl Med       Date:  1991

7.  Monoclonal antibody B72.3 in benign breast lesions.

Authors:  S Soomro; S Shousha
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

Review 8.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

9.  Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.

Authors:  F Buchegger; C Pfister; K Fournier; F Prevel; M Schreyer; S Carrel; J P Mach
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

10.  Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.

Authors:  K Irvine; J Schlom
Journal:  Cancer Immunol Immunother       Date:  1993-05       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.